The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen

Dermatology

Volumn 200, Issue 2, 2000, Pages 185-187

  Piérard, Gérald E ^a   Piérard Franchimont, Claudine ^b   Arrese, Jorge E ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE

Author keywords

Fungus; Nail; Onychomycosis; Sabouraud's agar

Indexed keywords

AGAR; ANTIFUNGAL AGENT; CHLORAMPHENICOL; ETICYCLIDINE; ITRACONAZOLE; MYCOLINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FUNGUS; HUMAN; HUMAN TISSUE; NAIL INFECTION; ONYCHOMYCOSIS; PILOT STUDY; PRIORITY JOURNAL;

EID: 0343963171     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018363     Document Type: Article

References (10)

1. De Doncker P, Decroix J, Piérard GE, Roelant D, Woestenborghs R, Jacqmin P, Odds F, Heremans A, Dockx P, Roseeuw D: Antifungal pulse therapy in onychomycosis: A pharmacokinetic/pharmacodynamic investigation of monthly cycles of 1 week pulse with itraconazole. Arch Dermatol 1996;132:34-41.
2. Piérard GE, Arrese JE, Piérard-Franchimont C: Treatment and prophylaxis of tinea infections. Drugs 1996;52:209-224.
3. De Doncker P, Gupta AK, Marynissen G, Stoffels P, Heremans A: Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview. J Am Acad Dermatol 1997;37:969-974.
4. Gupta AK, Shear NH: The new oral antifungal agents for onychomycosis of the toenails. J Eur Acad Dermatol Venereol 1999;13:1-13.
5. Arrese JE, Piérard-Franchimont C, Piérard GE: Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol 1999;38(suppl 2):1-6.
6. Piérard GE, Piérard-Franchimont C, Arrese JE: The boosted antifungal topical treatment (BATT) for onychomycosis. Med Mycol, in press.
7. Leyden J: Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol 1998:38:S42-S47.
8. Havu V, Brandt H, Heikkilä H, Hollmen A, Oksman R, Rantanen T, Saari S, Stubb S, Turjanmaa K, Piepponen T: Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: A pharmacokinetic comparison. Br J Dermatol 1999;140:96-101.
9. Hay RJ: New developments in antifungals. Int J Dermatol 1999;38(suppl 2):65-69.
10. De Doncker PRG, Scher RK, Baran RL, Decroix J, Degreef HJ, Rosecuw DI, Havu V, Rosen T, Gupta AK, Piérard GE: Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients. J Am Acad Dermatol 1997;36:173-177.